Forskning ved Københavns Universitet - Københavns Universitet

Forside

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Larsen, Michael
  • Ursula Schmidt-Erfurth
  • Paolo Lanzetta
  • Sebastian Wolf
  • Christian Simader
  • Erika Tokaji
  • Stefan Pilz
  • Annemarie Weisberger
  • MONT BLANC Study Group
To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.
OriginalsprogEngelsk
TidsskriftOphthalmology
Vol/bind119
Udgave nummer5
Sider (fra-til)992-1000
Antal sider9
ISSN0161-6420
DOI
StatusUdgivet - 2012

ID: 48509739